153 results
Page 4 of 8
8-K
EX-99.1
ko4w7
5 Nov 20
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
yhnq0 v3lmn
28 Sep 20
Heron Therapeutics Receives European Commission Authorization for ZYNRELEFTM (HTX-011) for the Treatment of Postoperative Pain
8:41am
8-K
EX-99.1
59vr421cnl
16 Sep 20
Regulation FD Disclosure
8:40am
8-K
EX-99.1
yzquuzyd6h
8 Sep 20
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
8:41am
8-K
EX-99.1
y7z3 tiaqaje5eskpb
5 Aug 20
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
v4m2cgr 8vr05
24 Jul 20
Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain
8:40am
8-K
EX-99.1
lc48ki
16 Jul 20
Heron Therapeutics Announces Initiation of
8:40am
8-K
EX-99.1
wiohm stlyw5
29 Jun 20
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
4:06pm
8-K
EX-99.1
oky 8h6b79
4 Jun 20
Regulation FD Disclosure
9:14am
8-K
EX-99.1
8zd 2zk38gcnf0puf2cr
18 May 20
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
9:11am
8-K
EX-99.1
btyp4m
6 May 20
Results of Operations and Financial Condition
9:10am
8-K
EX-99.1
oisknvbthj1
2 Mar 20
Results of Operations and Financial Condition
7:44am
8-K
EX-99.1
30581ouoly1rtx3tw7ze
19 Feb 20
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
4:37pm
8-K
EX-99.1
maln 76vgmhdvo
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.2
b9neo8qb
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.1
diy8ji6sgy
16 Dec 19
Regulation FD Disclosure
4:15pm